NO326639B1 - Farmasoytiske sammensetninger inneholdende et brusende syre-base par - Google Patents

Farmasoytiske sammensetninger inneholdende et brusende syre-base par Download PDF

Info

Publication number
NO326639B1
NO326639B1 NO19991376A NO991376A NO326639B1 NO 326639 B1 NO326639 B1 NO 326639B1 NO 19991376 A NO19991376 A NO 19991376A NO 991376 A NO991376 A NO 991376A NO 326639 B1 NO326639 B1 NO 326639B1
Authority
NO
Norway
Prior art keywords
effervescent
pharmaceutical composition
composition according
tablets
water
Prior art date
Application number
NO19991376A
Other languages
English (en)
Norwegian (no)
Other versions
NO991376L (no
NO991376D0 (no
Inventor
Paolo Chiesi
Paolo Ventura
Gaetano Brambilla
Rosa Mezzadri
Daniela Acerbi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO991376D0 publication Critical patent/NO991376D0/no
Publication of NO991376L publication Critical patent/NO991376L/no
Publication of NO326639B1 publication Critical patent/NO326639B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19991376A 1997-07-23 1999-03-22 Farmasoytiske sammensetninger inneholdende et brusende syre-base par NO326639B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001746A IT1293764B1 (it) 1997-07-23 1997-07-23 Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
PCT/EP1998/004517 WO1999004765A2 (en) 1997-07-23 1998-07-23 Pharmaceutical compositions containing an effervescent acid-base couple

Publications (3)

Publication Number Publication Date
NO991376D0 NO991376D0 (no) 1999-03-22
NO991376L NO991376L (no) 1999-05-25
NO326639B1 true NO326639B1 (no) 2009-01-26

Family

ID=11377613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991376A NO326639B1 (no) 1997-07-23 1999-03-22 Farmasoytiske sammensetninger inneholdende et brusende syre-base par

Country Status (27)

Country Link
US (1) US6284272B1 (ru)
EP (1) EP1003486B1 (ru)
JP (1) JP4801255B2 (ru)
KR (1) KR100528141B1 (ru)
CN (1) CN1138535C (ru)
AT (1) ATE232092T1 (ru)
AU (1) AU743186B2 (ru)
BG (1) BG64074B1 (ru)
BR (1) BR9801335B1 (ru)
CZ (1) CZ296221B6 (ru)
DE (1) DE69811236T2 (ru)
DK (1) DK1003486T3 (ru)
EA (1) EA002608B1 (ru)
ES (1) ES2191960T3 (ru)
HK (1) HK1029525A1 (ru)
HU (1) HU226115B1 (ru)
IL (1) IL134166A (ru)
IT (1) IT1293764B1 (ru)
NO (1) NO326639B1 (ru)
NZ (1) NZ502479A (ru)
OA (1) OA10999A (ru)
PL (1) PL199164B1 (ru)
PT (1) PT1003486E (ru)
SI (1) SI1003486T1 (ru)
SK (1) SK284551B6 (ru)
TR (1) TR199900675T1 (ru)
WO (1) WO1999004765A2 (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
CA2378525A1 (en) * 1999-07-02 2001-01-11 Sca Lohnherstellungs Ag A solid formulation of glucosamine sulphate
WO2001010405A1 (en) * 1999-08-04 2001-02-15 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
IN190018B (ru) * 1999-09-28 2003-05-31 Panacea Biotec Ltd
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
ATE329583T1 (de) * 2000-08-18 2006-07-15 Pharmacia Corp Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
US6531153B2 (en) * 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US6762153B2 (en) * 2001-10-18 2004-07-13 Rohm And Haas Company Delivery system for cyclopropenes
US20030091627A1 (en) * 2001-10-31 2003-05-15 Vinay Sharma Rate-controlled delivery of macrolides
KR100456273B1 (ko) * 2001-11-16 2004-11-10 김용년 산과 반응하여 일정 속도로 이산화탄소를 발생시킬 수있는 고상 제제 및 그의 제조 방법
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
AU2003219999A1 (en) 2002-03-06 2003-09-22 Lifizz, Inc. Effervescent compositions comprising bisphosphonates and methods related thereto
BG730Y1 (bg) * 2003-03-20 2005-04-30 Владимир НАЙДЕНОВ Ефервесцентна лекарствена форма
CN100445263C (zh) * 2003-04-24 2008-12-24 四川大学 甘氨酸钠碳酸盐的微波合成方法
SI2260871T1 (sl) 2004-04-01 2013-09-30 Pierre Fabre Medicament Kompleksi sestavin, ki vključujejo piroksikam, ciklodekstrin in arginin
FR2876911B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20070148238A1 (en) * 2005-06-23 2007-06-28 Spherics, Inc. Dosage forms for movement disorder treatment
CN100341488C (zh) * 2005-11-22 2007-10-10 瑞普(保定)生物药业有限公司 一种饮水免疫泡腾片及其制备方法
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
AU2007338631A1 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
EP2155159B1 (en) * 2007-05-08 2019-07-10 Hercules LLC Robust rapid disintegration tablet formulation
WO2009085306A1 (en) 2007-12-28 2009-07-09 Impax Laboratories, Inc. Controlled release formulations of levodopa and uses thereof
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2010011522A1 (en) 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
ES2533030T3 (es) * 2010-03-13 2015-04-07 Eastpond Laboratories Limited Composiciones que enlazan grasa
CN101836951B (zh) * 2010-05-20 2013-06-05 山东达因海洋生物制药股份有限公司 一种含盐酸氨溴索的口服溶液及其制备方法
CN102322123B (zh) * 2011-06-30 2013-09-18 德清艺玛工艺装饰有限公司 一种仿大理石泡沫装饰材料
CN102398378A (zh) * 2011-11-03 2012-04-04 北京华禧联合科技发展有限公司 镀铬冲模在硫酸氢氯吡格雷片制备过程中的应用
CA2894272A1 (en) * 2012-12-14 2014-06-19 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP3054929B1 (en) 2013-10-07 2020-08-05 Impax Laboratories, LLC Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP2870961B1 (en) * 2013-11-06 2018-07-18 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations of pramipexole
US11844860B2 (en) 2018-03-02 2023-12-19 Chiesi Farmaceutici S.P.A. Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
EP0252290B1 (en) * 1986-06-10 1992-06-03 CHIESI FARMACEUTICI S.p.A. Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
CH675537A5 (ru) * 1988-03-25 1990-10-15 Ciba Geigy Ag
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
DE69102900T3 (de) * 1990-02-14 1998-04-09 Otsuka Pharma Co Ltd Brausemischung, deren Herstellung sowie Verwendung.
US5252341A (en) * 1990-07-16 1993-10-12 Degussa Aktiengesellschaft Tablets and granulates containing mesna as active substance
JP2910425B2 (ja) * 1992-06-17 1999-06-23 和光純薬工業株式会社 発泡性錠剤の新規な製造方法
JP3170139B2 (ja) * 1994-04-08 2001-05-28 エスエス製薬株式会社 発泡性錠剤
FR2733420B1 (fr) * 1995-04-28 1997-06-27 Sep Tarral Preparations pectiques utilisables comme support de medicament
AU712710B2 (en) * 1996-05-17 1999-11-11 Merck Sharp & Dohme Corp. Effervescent bisphosphonate formulation

Also Published As

Publication number Publication date
HK1029525A1 (en) 2001-04-06
AU743186B2 (en) 2002-01-17
HUP0003897A3 (en) 2006-06-28
WO1999004765A3 (en) 1999-06-10
JP2001510789A (ja) 2001-08-07
ITMI971746A1 (it) 1999-01-23
OA10999A (en) 2001-11-07
PL338502A1 (en) 2000-11-06
BR9801335B1 (pt) 2010-09-21
ATE232092T1 (de) 2003-02-15
BR9801335A (pt) 1999-05-04
DK1003486T3 (da) 2003-05-19
KR100528141B1 (ko) 2005-11-15
AU8977798A (en) 1999-02-16
IL134166A (en) 2005-08-31
EP1003486B1 (en) 2003-02-05
CN1138535C (zh) 2004-02-18
BG103253A (en) 1999-09-30
HU226115B1 (en) 2008-04-28
NO991376L (no) 1999-05-25
SI1003486T1 (en) 2003-08-31
NO991376D0 (no) 1999-03-22
CZ2000255A3 (cs) 2000-07-12
CZ296221B6 (cs) 2006-02-15
US6284272B1 (en) 2001-09-04
WO1999004765A2 (en) 1999-02-04
SK922000A3 (en) 2000-07-11
DE69811236T2 (de) 2003-10-30
CN1267215A (zh) 2000-09-20
IT1293764B1 (it) 1999-03-10
NZ502479A (en) 2002-02-01
KR20010022140A (ko) 2001-03-15
DE69811236D1 (de) 2003-03-13
EA002608B1 (ru) 2002-06-27
BG64074B1 (bg) 2003-12-31
EP1003486A2 (en) 2000-05-31
PT1003486E (pt) 2003-06-30
SK284551B6 (sk) 2005-06-02
EA200000062A1 (ru) 2000-10-30
IL134166A0 (en) 2001-04-30
HUP0003897A2 (hu) 2001-08-28
TR199900675T1 (xx) 1999-11-22
JP4801255B2 (ja) 2011-10-26
ES2191960T3 (es) 2003-09-16
PL199164B1 (pl) 2008-08-29

Similar Documents

Publication Publication Date Title
NO326639B1 (no) Farmasoytiske sammensetninger inneholdende et brusende syre-base par
EP1863443B1 (en) Rapidly disintegrating dosage form comprising magnesium carbonate heavy
JP4965130B2 (ja) 乾式直打速崩壊性錠剤
US5401514A (en) Solid, fast-soluble pharmaceutical preparation containing S-(carboxymethyl)-L-cysteine and/or N-acetylcysteine
NO344546B1 (no) Legemiddelformuleringer med forbedrede farmakokinetiske egenskaper inneholdende vardenafil
JP2010053047A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
WO2014127786A1 (en) Orally disintegrating pharmaceutical composition comprising asenapine
US6667056B2 (en) Pharmaceutical compositions containing an effervescent acid-base couple
US9427421B2 (en) Effervescent compositions containing N-acetylcysteine
US20100047184A1 (en) Pharmaceutical compositions containing an effervescent acid-base couple
JP5476782B2 (ja) アルギニン含有錠剤の製造方法
WO2004089343A1 (en) Water soluble tablets
CA2297673C (en) Pharmaceutical compositions containing an effervescent acid-base couple
JP2017052755A (ja) 固形製剤
JP4393119B2 (ja) ヨウ化イソプロパミド含有製剤
MXPA00000754A (en) Pharmaceutical compositions containing an effervescent acid-base couple
JP4547161B2 (ja) 用時溶解型速溶性固形製剤
JP2019031491A (ja) 糖尿病治療剤
KR20110105550A (ko) 에카베트 또는 그의 염을 함유하는 경구용 정제

Legal Events

Date Code Title Description
MK1K Patent expired